DonaldJensenMDFACP, FAASLD
Gastroenterology • Chicago, ILHepatology & Liver Transplantation
Richard B Capps Emeritus Professor of Medicine Rush University Medical Center
Dr. Jensen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1725 W. Harrison Street
Suite 319
Chicago, IL 60612Phone+1 312-942-8910- Is this information wrong?
Summary
- Dr. Donald Jensen is a hepatologist in Chicago, IL and is affiliated with Rush University Medical Center. He received his medical degree from University of Illinois College of Medicine and has been in practice 45 years. He specializes in hepatology & liver transplantation and hepatitis C. In 2008, he was featured on Chicago Magazine's cover as Chicago's Top Doc. He is currently retired from clinical practice but is the Richard B. Capps Emeritus Professor at Rush.
Education & Training
Kings CollegeHepatology, Liver research, 1976 - 1978
Rush University Medical CenterResidency, Internal Medicine, 1972 - 1976
University of Illinois College of MedicineClass of 1972- University of Illinois at Urbana-ChampaignB.S., 1964 - 1968
- Rush University Medical CenterFellowship, Transplant Hepatology
Certifications & Licensure
IL State Medical License 1974 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- ALF Legacy Award American Liver Foundation, 2022
- AASLD Distinguished Service Asard AASLD, 2021
- Hepatology Attending of the Year Rush GI Fellows, 2019
- Join now to see all
Clinical Trials
- HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network Start of enrollment: 2011 Nov 01
Publications & Presentations
PubMed
- The American Association for the Study of Liver Diseases: A history of the first 10 years and its presidents.Donald M Jensen, Allison Rzepczynski, Emily E Jensen, Nancy Reau> ;Hepatology. 2022 Sep 1
- A Case of Rapid Decline in Alcohol-Associated Liver Disease.Aashesh N Verma, Donald M. Jensen> ;Clinical Liver Disease. 2021 Feb 1
- 16 citationsGlecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy.Thomas G. Cotter, Donald M. Jensen> ;Drug Design, Development and Therapy. 2019 Jul 29
- Join now to see all
Journal Articles
- Novel Educational Interventions in Residency Increase Knowledge of Chronic Liver Disease and Career Interest in HepatologyMikolajczyk AE, Farnan JM, McConville JF, Jensen DM, Reddy KG, Te HS, Reau N, Aronsohn AI, Hepatology, 1/10/2016
- Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancerKataria Y, Deaton RJ, Enk E, Jin M, Petrauskaite M, Dong L, Goldenberg JR, Cotler SJ, Jensen DM, van Breemen RB, Gann PH, BMC Gastroenterol, 1/1/2016
- Faldaprevir, pegylated interferon, and ribavirin for treatment-naive HCV genotype-1: pooled analysis of two phase 3 trialsJensen DM, Asselah T, Dieterich D, Foster GR, Sulkowski MS, Zeuzem S, Mantry P, Yoshida EM, Moreno C, Ouzan D, Wright M, Morano LE, Buynak R, Bourliere M, Hassanein T,..., Ann Hepatol, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Retinoid/Carotenoid Depletion in Hepatitis C: Fibrosis Stage in Relation to Serum Biomarkers for Antioxidant Status, Insulin Resistance & Oxidative Stress.Chung B, Rueter EE, Cotler S, Jensen DM, Guzman G, van Breemen R, Gann P, USCAP (United States and Canadian Academy of Pathology), 1/1/2014
- High rates of early viral response, promising safety profile and lack of resistance-related breakthrough in HCV GT ¼ patients treated with RG7128 plus PEGIFN alfa-2a (...Jensen DM, et al, Hepatology, AASLD (American Association for the Study of Liver Diseases), 1/1/2010
- Interferon is underutilized in hepatitis B (HBV) patients most likely to have a favorable outcome.eau N, Choi C, Te H, Mohanty S, Aronsohn A, Reddy G, Jensen DM, Hepatology, AASLD (American Association for the Study of Liver Diseases), 1/1/2010
- Join now to see all
Lectures
- The Financial Aspects of a Community Hepatologist.1/11/2016
- Are Hepatitis C Medications Too Expensive?Vienna - 1/22/2015
- Updated results of TARGET and TRIO studies. Focus on both compensated and decompensated cirrhosis with or without failure to first generation Pis.Baveno, Italy - 1/17/2015
- Join now to see all
Other
- Ductopenia and Vanishing Bile Duct Syndromes.Reau N and Jensen D, UpToDate
1/1/2007 - Current Developments in the Treatment of Hepatitis B and C.Reau NS, Jensen DM, US Infectious Diseases
1/1/2007 - Infectious complications following liver transplantation.Patil R and Jensen DM, UpToDate, vol 5.3, CD-ROM educational software
1/1/1999 - Join now to see all
Press Mentions
UChicago Medicine Biobank Helps Peg New Human VirusDecember 21st, 2015
Leading Liver and ID Experts to Develop Hepatitis C Practice RecommendationsFebruary 10th, 2016
Professional Memberships
- Member
- American Association for the Study of Liver DiseaseFellow
Hospital Affiliations
Rush Oak Park HospitalOak Park, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
